HCV NS3-4A 丝氨酸蛋白酶是由 NS3 及其辅因子 NS4A 组成的复合物。它具有丝氨酸蛋白酶以及 NTPase/RNA 解旋酶活性,对病毒多聚蛋白加工、RNA 复制和病毒体形成至关重要。
HCV NS3/4A 蛋白酶可有效裂解和灭活传感通路中的两种重要信号分子,这两种分子对 HCV 病原体相关分子模式 (PAMP) 作出反应以诱导干扰素 (IFN),即线粒体抗病毒信号蛋白 (MAVS) 和 Toll-IL-1 受体结构域含衔接子诱导 IFN-β (TRIF)。HCV 感染与慢性肝病有关,包括肝脂肪变性、纤维化、肝硬化和肝细胞癌。HCV的NS3-4A丝氨酸蛋白酶已成为开发针对HCV的特异性抗病毒药物最具吸引力的靶点之一。
HCV NS3-4A serine protease is a complex composed of NS3 and its cofactor NS4A. It harbours serine protease as well as NTPase/RNA helicase activities and is essential for viral polyprotein processing, RNA replication and virion formation.
The HCV NS3/4A protease efficiently cleaves and inactivates two important signaling molecules in the sensory pathways that react to HCV pathogen-associated molecular patterns (PAMPs) to induce interferons (IFNs), i.e., mitochondrial antiviral signaling protein (MAVS) and Toll-IL-1 receptor domain-containing adaptor inducing IFN-β (TRIF). HCV infection is associated with chronic liver disease, including hepatic steatosis, fibrosis, cirrhosis, and hepatocellular carcinoma. The NS3-4A serine protease of HCV has been one of the most attractive targets for developing specific antiviral agents against HCV.
© 2026 MolStrong. 保留所有权利。粤ICP备2023004355号
可通过CAS号进行批量搜索,一行一个CAS号